Millendo Therapeutics' Series B Round

Millendo Therapeutics raised a round of funding on January 04, 2016.

Millendo Therapeutics, previously known as Atterocor, is a drug development company focused on a treatment for adrenal cancer. The company seeks to develop adrenal-targeting therapy for the treatment …

Articles about Millendo Therapeutics' Series B Round: